These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
245 related articles for article (PubMed ID: 21947386)
41. A PCT algorithm for discontinuation of antibiotic therapy is a cost-effective way to reduce antibiotic exposure in adult intensive care patients with sepsis. Kip MM; Kusters R; IJzerman MJ; Steuten LM J Med Econ; 2015; 18(11):944-53. PubMed ID: 26105574 [TBL] [Abstract][Full Text] [Related]
42. Do we need new trials of procalcitonin-guided antibiotic therapy? Lisboa T; Salluh J; Povoa P Crit Care; 2018 Jan; 22(1):17. PubMed ID: 29373980 [TBL] [Abstract][Full Text] [Related]
43. Economic evaluation of procalcitonin-guided antibiotic therapy in acute respiratory infections: a US health system perspective. Schuetz P; Balk R; Briel M; Kutz A; Christ-Crain M; Stolz D; Bouadma L; Wolff M; Kristoffersen KB; Wei L; Burkhardt O; Welte T; Schroeder S; Nobre V; Tamm M; Bhatnagar N; Bucher HC; Luyt CE; Chastre J; Tubach F; Mueller B; Lacey MJ; Ohsfeldt RL; Scheibling CM; Schneider JE Clin Chem Lab Med; 2015 Mar; 53(4):583-92. PubMed ID: 25581762 [TBL] [Abstract][Full Text] [Related]
44. Clinical and economic impact of procalcitonin to shorten antimicrobial therapy in septic patients with proven bacterial infection in an intensive care setting. Deliberato RO; Marra AR; Sanches PR; Martino MD; Ferreira CE; Pasternak J; Paes AT; Pinto LM; dos Santos OF; Edmond MB Diagn Microbiol Infect Dis; 2013 Jul; 76(3):266-71. PubMed ID: 23711530 [TBL] [Abstract][Full Text] [Related]
45. Efficacy and safety of procalcitonin guidance in reducing the duration of antibiotic treatment in critically ill patients: a randomised, controlled, open-label trial. de Jong E; van Oers JA; Beishuizen A; Vos P; Vermeijden WJ; Haas LE; Loef BG; Dormans T; van Melsen GC; Kluiters YC; Kemperman H; van den Elsen MJ; Schouten JA; Streefkerk JO; Krabbe HG; Kieft H; Kluge GH; van Dam VC; van Pelt J; Bormans L; Otten MB; Reidinga AC; Endeman H; Twisk JW; van de Garde EMW; de Smet AMGA; Kesecioglu J; Girbes AR; Nijsten MW; de Lange DW Lancet Infect Dis; 2016 Jul; 16(7):819-827. PubMed ID: 26947523 [TBL] [Abstract][Full Text] [Related]
46. [Role of procalcitonin in monitoring the antibiotic therapy in septic surgical patients]. Pundiche M; Sârbu V; Unc OD; Grasa C; Martinescu A; Bădărău V; Durbală I; Sapte E; Pasăre R; Voineagu L; Iordache I; Vâncă A; Adam A Chirurgia (Bucur); 2012; 107(1):71-8. PubMed ID: 22480120 [TBL] [Abstract][Full Text] [Related]
47. Antibiotic consumption after implementation of a procalcitonin-guided antimicrobial stewardship programme in surgical patients admitted to an intensive care unit: a retrospective before-and-after analysis. Hohn A; Heising B; Hertel S; Baumgarten G; Hochreiter M; Schroeder S Infection; 2015 Aug; 43(4):405-12. PubMed ID: 25588968 [TBL] [Abstract][Full Text] [Related]
48. Procalcitonin-guided algorithms of antibiotic therapy in the intensive care unit: a systematic review and meta-analysis of randomized controlled trials. Kopterides P; Siempos II; Tsangaris I; Tsantes A; Armaganidis A Crit Care Med; 2010 Nov; 38(11):2229-41. PubMed ID: 20729729 [TBL] [Abstract][Full Text] [Related]
49. Can procalcitonin levels guide antibiotic therapy in bacterial infections and reduce antibiotic overconsumption without having a negative effect on clinical outcomes? Sandifer JP; Jones AE Ann Emerg Med; 2012 Sep; 60(3):370-1. PubMed ID: 22305332 [No Abstract] [Full Text] [Related]
50. Procalcitonin for guidance of antibiotic therapy. Schuetz P; Albrich W; Christ-Crain M; Chastre J; Mueller B Expert Rev Anti Infect Ther; 2010 May; 8(5):575-87. PubMed ID: 20455686 [TBL] [Abstract][Full Text] [Related]
51. Procalcitonin-guided antibiotic use in acute respiratory tract infections. Bollu M; Marte-Grau AC; Bobba RK Arch Intern Med; 2009 Apr; 169(7):716. PubMed ID: 19365003 [No Abstract] [Full Text] [Related]
52. Procalcitonin (PCT)-guided algorithm reduces length of antibiotic treatment in surgical intensive care patients with severe sepsis: results of a prospective randomized study. Schroeder S; Hochreiter M; Koehler T; Schweiger AM; Bein B; Keck FS; von Spiegel T Langenbecks Arch Surg; 2009 Mar; 394(2):221-6. PubMed ID: 19034493 [TBL] [Abstract][Full Text] [Related]
53. Procalcitonin to guide duration of antimicrobial therapy in intensive care units: a systematic review. Agarwal R; Schwartz DN Clin Infect Dis; 2011 Aug; 53(4):379-87. PubMed ID: 21810753 [TBL] [Abstract][Full Text] [Related]
54. Procalcitonin-guided therapy may reduce length of antibiotic treatment in intensive care unit patients with secondary peritonitis: A multicenter retrospective study. Maseda E; Suarez-de-la-Rica A; Anillo V; Tamayo E; García-Bernedo CA; Ramasco F; Villagran MJ; Maggi G; Gimenez MJ; Aguilar L; Granizo JJ; Buño A; Gilsanz F J Crit Care; 2015 Jun; 30(3):537-42. PubMed ID: 25600574 [TBL] [Abstract][Full Text] [Related]
55. Excluding infection through procalcitonin testing improves outcomes of congestive heart failure patients presenting with acute respiratory symptoms: results from the randomized ProHOSP trial. Schuetz P; Kutz A; Grolimund E; Haubitz S; Demann D; Vögeli A; Hitz F; Christ-Crain M; Thomann R; Falconnier C; Hoess C; Henzen C; Marlowe RJ; Zimmerli W; Mueller B; Int J Cardiol; 2014 Aug; 175(3):464-72. PubMed ID: 25005339 [TBL] [Abstract][Full Text] [Related]